1-20 of 24
glucagon-like peptide-1 agonists
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

About Kenneth Cusi: Guest Editor

Journal: Diabetes Spectrum
Diabetes Spectr 2024;37(1):8
https://doi.org/10.2337/ds24-ge01
Published: 15 February 2024
View article titled, About Kenneth Cusi: Guest Editor
Open the PDF for About Kenneth Cusi: Guest Editor in another window
Journal Articles

Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies

Idoia Genua, Kenneth Cusi
Journal: Diabetes Spectrum
Diabetes Spectr 2024;37(1):48–58
https://doi.org/10.2337/dsi23-0012
Published: 15 February 2024
View article titled, Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies
Open the PDF for Pharmacological Approaches to Nonalcoholic Fatty Liver Disease: Current and Future Therapies in another window
Journal Articles

Characterizing Prescribing Patterns of Diabetes Medications at an Adult Medicine Clinic: A Focus on Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors

Ashley N. Shtoyko, Meaghan B. Murphy, Jenna L. Harris, Caitlin Toomey, Elizabeth M. Phillips
Journal: Diabetes Spectrum
Diabetes Spectr 2024;37(2):180–185
https://doi.org/10.2337/ds22-0095
Published: 05 January 2024
View article titled, Characterizing Prescribing Patterns of Diabetes Medications at an Adult Medicine Clinic: A Focus on Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
Open the PDF for Characterizing Prescribing Patterns of Diabetes Medications at an Adult Medicine Clinic: A Focus on Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors in another window
Journal Articles

Liraglutide and Robust A1C Reductions Among People With Type 2 Diabetes Requiring Appetite Control: A Review of Two Cases

Mason A. Pitts, Ryanne H. Griggs, Macey R. Hall, McKinley S. Tankersley, Jeremy L. Johnson
Journal: Diabetes Spectrum
Diabetes Spectr 2024;37(2):175–179
https://doi.org/10.2337/ds23-0052
Published: 14 December 2023
View article titled, Liraglutide and Robust A1C Reductions Among People With Type 2 Diabetes Requiring Appetite Control: A Review of Two Cases
Open the PDF for Liraglutide and Robust A1C Reductions Among People With Type 2 Diabetes Requiring Appetite Control: A Review of Two Cases in another window
Journal Articles

Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions

Andrew P. Demidowich, Kristine Batty, Mihail Zilbermint
Journal: Diabetes Spectrum
Diabetes Spectr 2022;35(4):440–451
https://doi.org/10.2337/dsi22-0013
Published: 15 November 2022
View article titled, Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions
Open the PDF for Instituting a Successful Discharge Plan for Patients With Type 2 Diabetes: Challenges and Solutions in another window
Journal Articles

Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes

Sara A. Wettergreen, Morgan P. Stewart, Katelyn Kennedy, Jennifer M. Trujillo
Journal: Diabetes Spectrum
Diabetes Spectr 2023;36(1):5–13
https://doi.org/10.2337/ds21-0108
Published: 29 June 2022
View article titled, Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes
Open the PDF for Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes in another window
Journal Articles

Cardiovascular Outcomes Trials of Incretin-Based Therapies

Tina K. Thethi, Anika Bilal, Richard E. Pratley
Journal: Diabetes Spectrum
Diabetes Spectr 2021;34(3):217–224
https://doi.org/10.2337/ds20-0072
Published: 18 August 2021
View article titled, Cardiovascular Outcomes Trials of Incretin-Based Therapies
Open the PDF for Cardiovascular Outcomes Trials of Incretin-Based Therapies in another window
Journal Articles

Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes

Carolina Solis-Herrera, Eugenio Cersosimo, Curtis Triplitt
Journal: Diabetes Spectrum
Diabetes Spectr 2021;34(3):248–256
https://doi.org/10.2337/ds20-0067
Published: 18 August 2021
View article titled, Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes
Open the PDF for Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes in another window
Journal Articles

Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study

Timothy S. Bailey, Pierre Evenou, Jasvinder Gill, Paulos Berhanu, Romain Raymond, Jodi Strong, Eugene E. Wright, Jr.
Journal: Diabetes Spectrum
Diabetes Spectr 2021;34(4):407–418
https://doi.org/10.2337/ds20-0079
Published: 10 August 2021
View article titled, Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study
Open the PDF for Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study in another window
Journal Articles

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study

William Polonsky, Cory Gamble, Neeraj Iyer, Mona Martin, Carol Hamersky
Journal: Diabetes Spectrum
Diabetes Spectr 2021;34(2):175–183
https://doi.org/10.2337/ds20-0025
Published: 02 February 2021
View article titled, Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study
Open the PDF for Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study in another window
Journal Articles

Optimizing Therapeutic Outcomes With Oral Semaglutide: A Patient-Centered Approach

Diana M. Isaacs, Davida F. Kruger, Geralyn R. Spollett
Journal: Diabetes Spectrum
Diabetes Spectr 2021;34(1):7–19
https://doi.org/10.2337/ds20-0016
Published: 01 February 2021
View article titled, Optimizing Therapeutic Outcomes With Oral Semaglutide: A Patient-Centered Approach
Open the PDF for Optimizing Therapeutic Outcomes With Oral Semaglutide: A Patient-Centered Approach in another window
Journal Articles

Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes

Nicole Ehrhardt, Sasan Fazeli, Sanjana Rao, Richard Amdur
Journal: Diabetes Spectrum
Diabetes Spectr 2020;33(2):182–189
https://doi.org/10.2337/ds19-0025
Published: 01 May 2020
View article titled, Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes
Open the PDF for Use of Premixed Insulin, Metformin, and a Glucagon-Like Peptide 1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes in another window
Journal Articles

Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes

John E. Anderson
Journal: Diabetes Spectrum
Diabetes Spectr 2020;33(2):165–174
https://doi.org/10.2337/ds19-0031
Published: 01 May 2020
View article titled, Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes
Open the PDF for Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes in another window
Journal Articles

Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes

Sara E. Lingow, Sandra D. Burke, Amie D. Brooks, Pat S. Rafferty
Journal: Diabetes Spectrum
Diabetes Spectr 2019;32(2):164–170
https://doi.org/10.2337/ds18-0058
Published: 01 May 2019
View article titled, Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes
Open the PDF for Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes in another window
Journal Articles

Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices

Anna Y. Zhou, Jennifer M. Trujillo
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(4):359–366
https://doi.org/10.2337/ds17-0048
Published: 01 November 2018
View article titled, Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices
Open the PDF for Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices in another window
Journal Articles

Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin

Andrew D. Santeusanio, Monica M. Bowen
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(3):261–266
https://doi.org/10.2337/ds17-0068
Published: 01 August 2018
View article titled, Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin
Open the PDF for Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin in another window
Journal Articles

iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes

Debbie Hinnen, Jodi Strong
Journal: Diabetes Spectrum
Diabetes Spectr 2018;31(2):145–154
https://doi.org/10.2337/ds17-0014
Published: 01 May 2018
View article titled, iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes
Open the PDF for iGlarLixi: A New Once-Daily Fixed-Ratio Combination of Basal Insulin Glargine and Lixisenatide for the Management of Type 2 Diabetes in another window
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes

Deborah Hinnen
Journal: Diabetes Spectrum
Diabetes Spectr 2017;30(3):202–210
https://doi.org/10.2337/ds16-0026
Published: 01 August 2017
View article titled, Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes in another window
Journal Articles

Basal Insulin Use With GLP-1 Receptor Agonists

Sarah L. Anderson, Jennifer M. Trujillo
Journal: Diabetes Spectrum
Diabetes Spectr 2016;29(3):152–160
https://doi.org/10.2337/diaspect.29.3.152
Published: 01 August 2016
View article titled, Basal Insulin Use With GLP-1 Receptor Agonists
Open the PDF for Basal Insulin Use With GLP-1 Receptor Agonists in another window
Journal Articles

Management of Hyperglycemia in Diabetic Kidney Disease

Joshua J. Neumiller, Irl B. Hirsch
Journal: Diabetes Spectrum
Diabetes Spectr 2015;28(3):214–219
https://doi.org/10.2337/diaspect.28.3.214
Published: 01 August 2015
View article titled, Management of Hyperglycemia in Diabetic Kidney Disease
Open the PDF for Management of Hyperglycemia in Diabetic Kidney Disease in another window